ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1129–1140 of 2020 project topics
Variant Classification and Interpretation as a Service Platform
API-driven platform that provides automated and expert-curated variant pathogenicity classification, clinician-facing interpretation reports, and continuously updated evidence databases for genetic testing laboratories. Generates SaaS revenue through usage-based pricing while enabling smaller laboratories to offer comprehensive genomic analysis without building internal bioinformatics expertise.
Genetic Testing Platform Technologies Click to view more details →
Prenatal and Newborn Screening Integration Platform with Risk Stratification
Integrated testing platform combining non-invasive prenatal testing, expanded newborn screening, and early-life genetic disease risk assessment through a unified sample management and reporting system. Captures market growth in preventive pediatric genetics while establishing long-term patient relationships and recurring revenue opportunities through tiered screening packages.
Genetic Testing Platform Technologies Click to view more details →
TP53 Li-Fraumeni Syndrome Comprehensive Testing
Developing comprehensive TP53 testing and counseling protocols for Li-Fraumeni syndrome families including variant classification and surveillance guidelines.
Genetic Basis of Childhood Cancer Predisposition Click to view more details →
Retinoblastoma RB1 Gene Testing
Applying RB1 sequencing, MLPA, and methylation analysis for diagnosing hereditary retinoblastoma and optimizing cascade testing in families.
Genetic Basis of Childhood Cancer Predisposition Click to view more details →
Wilms Tumor Genetic Predisposition Testing
Testing WT1, CTNNB1, WTX, and 11p15 imprinting for Wilms tumor predisposition in patients with bilateral or familial cases.
Genetic Basis of Childhood Cancer Predisposition Click to view more details →
Constitutional Mismatch Repair Deficiency Diagnosis
Identifying biallelic MMR gene mutations causing CMMRD syndrome in children with multiple malignancies for diagnosis and family cascade testing.
Genetic Basis of Childhood Cancer Predisposition Click to view more details →
BRCA1/BRCA2 Hereditary Cancer Risk SaaS Platform
A cloud-based diagnostic platform that integrates BRCA1 and BRCA2 sequencing with AI-powered risk stratification algorithms to identify pediatric breast and ovarian cancer predisposition. This platform enables laboratories and clinics to offer standardized testing with automated reporting, generating recurring subscription revenue and premium interpretation services.
Genetic Basis of Childhood Cancer Predisposition Click to view more details →
Neurofibromatosis Type 1 NF1 Digital Screening Tool
A mobile and web-based application that screens for NF1 gene mutations associated with childhood optic pathway gliomas and other malignancies through guided clinical assessment workflows. The tool captures patient data and delivers commercial value through licensing fees to pediatric oncology centers and telehealth providers serving high-risk populations.
Genetic Basis of Childhood Cancer Predisposition Click to view more details →
Familial Adenomatous Polyposis APC Gene Testing Platform
An integrated laboratory information system that automates APC gene variant detection and stratifies colorectal cancer risk in pediatric and young adult patients with family history. The platform monetizes through per-test fees, data licensing to pharmaceutical companies developing preventive therapies, and family screening management subscription services.
Genetic Basis of Childhood Cancer Predisposition Click to view more details →
Hereditary Diffuse Gastric Cancer CDH1 Mutation Detection
A next-generation sequencing diagnostic service coupled with clinical decision support software that identifies CDH1 pathogenic variants in children with familial gastric cancer predisposition. Revenue streams include testing fees, premium genetic counseling platform subscriptions, and partnerships with international cancer registries tracking early-onset cases.
Genetic Basis of Childhood Cancer Predisposition Click to view more details →
Gorlin Syndrome PTCH1 Risk Stratification Commercial Service
A comprehensive genetic testing and phenotype-genotype prediction platform that identifies PTCH1 mutations associated with medulloblastoma and rhabdomyosarcoma in children with nevoid basal cell carcinoma syndrome. The service generates revenue through diagnostic testing fees, surveillance protocol licensing to pediatric centers, and longitudinal patient data analytics sold to research institutions.
Genetic Basis of Childhood Cancer Predisposition Click to view more details →
Peutz-Jeghers Syndrome STK11 Pediatric Surveillance Dashboard
A SaaS platform that combines STK11 genetic testing with personalized gastrointestinal and pancreatic cancer surveillance protocols for affected children and adolescents. The platform drives commercial value through annual institutional subscriptions, integration fees with electronic health records systems, and premium features for predictive risk modeling and family management.
Genetic Basis of Childhood Cancer Predisposition Click to view more details →